Science 37
Uses advanced telemedicine technology and patient-centric innovative networked clinical research models to rapidly accelerate biomedical discovery and bring down the costs of clinical trials.
Market cap
$34.7m
Enterprise value
($21m)
Share price
$5.75 SNCE
Recent deals
loading funding rounds…
Glynn Capital Management(exited)
GV(exited)
Amgen Ventures(exited)
Lux Capital(exited)
Redmile Group(exited)
Sanofi Ventures(exited)
dRx Capital(exited)
Arthur Iinuma(exited)
Sanofi-Genzyme BioVentures(exited)
PPD(exited)
Novartis(exited)
Amgen(exited)
LifeSci Venture Partners(exited)
Mubadala Capital(exited)
LifeSci Acquisition II Corp(exited)
Inertia Ventures(exited)
Ayman Alabdallah(exited)
Arthur Iinuma(exited)
Sahsen Ventures(exited)
Alaa Halawa(exited)
| USD | 2020 | 2021 | 2022 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | 151 % | 18 % |
| EBITDA | 0000 | 0000 | 0000 |
| % EBITDA margin | (112 %) | (41 %) | (199 %) |
| Profit | 0000 | 0000 | 0000 |
| % profit margin | (134 %) | (158 %) | (73 %) |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Science 37
Edit
ACQUISITION by Science 37 Feb 2023